Considerations in perioperative assessment of valproic acid coagulopathy

Journal of Anaesthesiology Clinical Pharmacology

Volumn 30, Issue 1, 2014, Pages 7-9

  Abdallah, Claude ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adverse effects; anesthesia; coagulation disorders; perioperative care; valproic acid

Indexed keywords

EID: 84893470154     PISSN: 09709185     EISSN: 22312730     Source Type: Journal    
DOI: 10.4103/0970-9185.125685     Document Type: Article

References (22)

1. Bourgeois BF. Valproic acid Clinical use. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic Drugs. 4 th ed. New York: Raven Press; 1995. p. 633-9.
2. Battino D, Estienne M, Avanzini G. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide. Clin Pharmacokinet 1995;29:257-86
3. Gerstner T, Teich M, Bell N, Longin E, Dempfle CE, Brand J, et al. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia 2006;47:1136-43 (Pubitemid 44086748)
4. Serdaroglu G, Tütüncüoglu S, Kavakli K, Tekgül H. Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acid. J Child Neurol 2002;17:41-3 (Pubitemid 34406886)
5. Raghuveer TS, Srinivasa R, Chandrasekhara MK. Valproate induced bleeding. Indian Pediatr 1989;26:596-7 (Pubitemid 19178868)
6. Köse G, Arhan E, Unal B, Ozaydin E, Guven A, Sayli TR. Valproate-associated coagulopathies in children during short-term treatment. J Child Neurol 2009;24:1493-8
7. Koenig S, Gerstner T, Keller A, Teich M, Longin E, Dempfle CE. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: A prospective study. Blood Coagul Fibrinolysis 2008;19:375-82
8. Ugras M, Yakinci C. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate. Brain Dev 2006;28:549-53 (Pubitemid 44293172)
9. Verrotti A, Greco R, Matera V, Altobelli E, Morgese G, Chiarelli F. Platelet count and function in children receiving sodium valproate. Pediatr Neurol 1999;21:611-4 (Pubitemid 29460993)
10. Kreuz W, Linde R, Funk M, Meyer-Schrod R, Föll E, Nowak-Göttl U, et al. Valproate therapy induces von Willebrand disease type I. Epilepsia 1992;33:178-84
11. Delgado MR, Riela AR, Mills J, Browne R, Roach ES. Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol 1994;9:311-4 (Pubitemid 24255252)
12. Ko CH, Kong CK, Tse PW. Valproic acid and thrombocytopenia: Cross-sectional study. Hong Kong Med J 2001;7:15-21 (Pubitemid 32769476)
13. Trannel TJ, Ahmed I, Goebert D. Occurrence of thrombocytopenia in psychiatric patients taking valproate. Am J Psychiatry 2001;158:128-30 (Pubitemid 32047259)
14. Vasudev K, Keown P, Gibb I, McAllister-Williams RH Hematological effects of valproate in psychiatric patients: What are the risk factors? J Clin Psychopharmacol 2010 30 282-5
15. Schädlich D, Friebel D, Schallner J, Gehrisch S, Siegert G, Kuhlisch E, et al. Evaluation of haemostasis in children treated with valproic acid. Hamostaseologie 2010;30 Suppl 1:S132-7
16. Teich M, Longin E, Dempfle CE, König S. Factor XIII deficiency associated with valproate treatment. Epilepsia 2004;45:187-9 (Pubitemid 38174126)
17. Cannizzaro E, Albisetti M, Wohlrab G, Schmugge M. Severe bleeding complications during antiepileptic treatment with valproic acid in children. Neuropediatrics 2007;38:42-5 (Pubitemid 47226922)
18. Israelian LA, Lubnin AIu, Tsetlin AM, Stepanenko AIu, Kazarian AA, Golovteev AL, et al. Hemostatic disorders caused by chronic use of valproic acid in neurosurgical patients. Thromboelastographic monitoring. Anesteziol Reanimatol 2010; 4 50-4
19. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and pain medicine evidence-based guidelines (Third Edition). Reg Anesth Pain Med 2010;35:64-101
20. Acharya S, Bussel JB. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 2000;22:62-5 (Pubitemid 32266840)
21. Kis B, Szupera Z, Mezei Z, Gecse A, Telegdy G, Vécsei L. Valproate treatment and platelet function: The role of arachidonate metabolites. Epilepsia 1999;40:307-10 (Pubitemid 29164794)
22. Kumar S. Valproate-induced bleeding: Report of two cases and review of literature. Indian Pediatr 2005;42:833-4. (Pubitemid 41207504)